Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies.
NVS Key Statistics
NVS News
Key Points Novartis AG maintains a highly profitable portfolio of innovative medicines with significant net margins. Teva Pharmaceutical Industries is executi...
...
The acquisition would add Myricx’s N-myristoyltransferase inhibitor (NMTi) payload platform, which is designed to deliver targeted cancer therapies with a novel...
Analyst ratings
46%
of 28 ratingsMore NVS News
Swiss pharmaceutical company Novartis (NVS) agreed to acquire UK-based private biotech firm Myricx Bio for $1.5 billion, including $1.1 billion upfront in cash....
Novartis (NVS) announced that it has entered into an agreement to acquire Myricx Bio, a privately held UK-based biotechnology company developing a new class of...
Myricx Bio, a UK-headquartered biotech company, announced that it has reached agreement to be acquired by Novartis (NVS) for up to $1.5B including $1.1B cash up...
Novartis will pay $1.1 billion upfront for Myricx Bio, with up to $400 million in potential additional payments. Mike Blake / Reuters Novartis NOVN -0.08 %decr...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.